With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
NDAQ trades against a final fair-value range of $52.90-$87.67, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
A prolonged capital markets weakness stifles IPOs and volume, while competition in data and technology products pressures pricing power. The market abruptly reprices the expected normalized multiple.
A multi-year drought in capital markets activity suppresses high-margin listings and trading revenue far beyond the anticipated near-term contraction.
Strict regulatory intervention caps the pricing of proprietary market data feeds, structurally impairing a highly recurring revenue stream.
Aggressive competition from rival exchanges structurally erodes Nasdaq's core listing market share, weakening its overarching network effects.
| Line item | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
|---|---|---|---|---|---|---|
| Revenue | — | $6.23B | $6.06B-2.7% | $7.40B+22.1% | $8.26B+11.6% | +7.3% |
| Gross profit | — | $2.34B | $2.55B | $2.99B | $3.49B | +10.5% |
| Operating income | — | $1.66B | $1.81B | $1.95B | $2.43B | +10.0% |
| Net income | — | $1.13B | $1.06B-6.2% | $1.12B+5.7% | $1.79B+59.8% | +12.3% |
| EPS (diluted) | $2.35 | $2.26 | $2.08 | $1.93 | $3.09 | +7.1% |
| EBITDA | — | $1.85B | $2.00B | $2.46B | $3.13B | +14.0% |
| R&D | — | — | — | — | — | — |
| SG&A | — | $420.0M | $417.0M | $427.0M | $424.0M | +0.2% |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Deterioration versus the report thesis |
| Decline in recurring revenue growth rates. | Monitor | Deterioration versus the report thesis |
| Deterioration in OCF to Net Income conversion below 1.0x. | Monitor | Deterioration versus the report thesis |
